血必净注射液联合抗生素治疗重症肺炎36例临床观察

摘要

Objective To investigate the clinical effect of Xuebijing Injection combined with antibiotics in the treatment of severe pneu-monia. Methods A total of 36 patients with severe pneumonia in our hospital were randomly divided into the control group and the treatment group, 18 cases in each group. The control group was treated with antibiotics, the treatment group was treated with Xuebijing Injection combined with antibiotics. After 2 weeks of continuous treatment, the therapeutic effects of the two groups were com-pared. Results The total effective rate of the treatment group was 94. 44％, which was significantly higher than 66. 67％ of the control group ( P < 0. 05 ) . The white blood cell counts ( WBC ) , carbon dioxide partial pressure ( PCO2 ) , partial pressure of oxygen ( PO2 ) between the two groups were significantly different ( P < 0. 05 ) . Conclusion Xuebijing Injection combined with antibiotics in the treatment of severe pneumonia can improve the pulmonary function, reduce inflammatory factor in serum, and it has high curative effect, which is worthy of clinical promotion.%目的 探讨血必净注射液联合抗生素治疗重症肺炎的疗效.方法 将2013年7月至2016年12月收治的重症肺炎患者36例按照诊疗编号随机分为对照组和治疗组,每组18例.对照组患者采用抗生素治疗,治疗组患者在此基础上联合血必净注射液治疗,持续治疗2周后,比较两组患者的疗效.结果 治疗组患者总有效率为94.44％,高于对照组的66.67％(P<0.05);治疗组患者白细胞计数(WBC)、二氧化碳分压(PaCO2)、氧分压(PaO2)均与对照组差异明显(P<0.05).结论 血必净注射液联合抗生素治疗重症肺炎,可改善患者的肺功能,降低血清中的炎性因子含量,疗效较好,值得临床推广.